Gents,
My bio says it all. Some bad luck recently. I failed what may be the hottest immunotherapy therapy trial in the world (the “BiTE protocol) but then again half the men on the trial see no benefit and the scientists don’t know why, yet. If anything I and a fellow patient feel like the immunotherapy drugs supercharged our prostate cancer!
Before I could start my next trial drug, which involves an “anti-trop” drug, I was told that an MRI showed two small brain tumors. These were treated last week with “gamma knife,” a trial requirement. I also had my bladder irradiated (palliative care). So my new trial has been delayed since mid-March and my PSA doubling time is 3 weeks. With prostate cancer growing in the lungs and liver, too,
My question: I was given a choice between starting this new trial and starting Jevtana/carboplatin. My new trial oncologist says that the trial drug has been shown to cross the blood-brain barrier whereas Jevtana/carboplatin doesn’t do so well. The BiTE trial oncologist recommended the chemotherapy.
So I chose to wait and start the trial drug next week. What would you have done if you were in my shoes?